US Map / Oregon
State OR

Clinical Trials in Oregon

Oregon is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oregon and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 195 actively recruiting studies with Oregon sites out of 195 registered in total. The busiest research areas in Oregon are Breast Cancer, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Oregon Health and Science University, National Cancer Institute (NCI), VA Office of Research and Development. By stage, Oregon trials break down as Phase 1 (25), Phase 2 (49), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
195
Recruiting Now
195
← Back to US Map
Top Conditions in Oregon
Breast Cancer (7)Endometrial Cancer (6)Advanced Solid Tumor (5)Ovarian Cancer (4)Colorectal Cancer (4)Multiple Myeloma (4)Metastatic Solid Tumor (3)Cancer (3)Lung Cancer (3)Prostate Cancer (3)Thyroid Cancer (3)NSCLC (Non-small Cell Lung Cancer) (3)

Frequently Asked Questions — Clinical Trials in Oregon

How many clinical trials are currently recruiting in Oregon?
ClinicalMetric currently tracks 195 actively recruiting clinical trials with at least one location in Oregon. The total number of registered studies—including active but not currently enrolling trials—is 195. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oregon?
Oregon hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oregon serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oregon?
To join a clinical trial in Oregon, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oregon maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oregon

NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07589595 Phase 2
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (T...
Condition
Cognitive Dysfunction
Enrollment
350 pts
Location
United States, Japan, South Korea
Sponsor
Eli Lilly and Company
View Trial →
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06072430 Phase 3
Recruiting
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment ...
Condition
Septic Shock
Enrollment
46 pts
Location
United States
Sponsor
Vivacelle Bio
View Trial →
NCT06881992 Phase 3
Recruiting
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Condition
Tumor Hyperinsulinism (Tumor HI)
Enrollment
16 pts
Location
United States, France, Netherlands
Sponsor
Rezolute
View Trial →
NCT05486572 N/A
Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Condition
Carcinoma, Hepatocellular
Enrollment
4,700 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06312137 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzum...
Condition
Non Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT06535178 N/A
Recruiting
The Influence of Sleep on Cardiovascular Outcomes
Condition
Circadian Rhythm
Enrollment
30 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT05703971 Phase 1, Phase 2
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SC...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
62 pts
Location
United States
Sponsor
Genprex, Inc.
View Trial →
NCT07285655 Phase 3
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH...
Condition
Pulmonary Hypertension Due to Lung Disease (Disorder)
Enrollment
344 pts
Location
United States, Austria, Belgium
Sponsor
Liquidia Technologies, Inc.
View Trial →
NCT07011576 Phase 2
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants W...
Condition
Colon Cancer
Enrollment
60 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT06011499 N/A
Recruiting
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Can...
Condition
Prostate Carcinoma
Enrollment
250 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
View Trial →
NCT07296744 N/A
Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous...
Condition
Coronary Artery Disease
Enrollment
358 pts
Location
United States
Sponsor
Supira Medical
View Trial →
NCT07007793 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary...
Condition
Primary Hyperaldosteronism
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT03489278 N/A
Recruiting
Clinical Procedures to Support Research in ALS
Condition
Amyotrophic Lateral Sclerosis
Enrollment
1,200 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07254806 Phase 3
Recruiting
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subj...
Condition
Degenerative Disc Disease
Enrollment
162 pts
Location
United States
Sponsor
DiscGenics, Inc.
View Trial →
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
View Trial →
NCT07169409 Phase 1
Recruiting
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vuln...
Condition
Opioid Use Disorder
Enrollment
250 pts
Location
United States
Sponsor
Boulder Care
View Trial →
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5...
Condition
Advanced Solid Tumor
Enrollment
300 pts
Location
United States, Australia, France
Sponsor
PMV Pharmaceuticals, Inc
View Trial →
NCT06728774 N/A
Recruiting
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Def...
Condition
Major Depressive Disorder (MDD)
Enrollment
24 pts
Location
United States
Sponsor
Portland VA Medical Center
View Trial →
NCT06465329 Phase 2
Recruiting
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus...
Condition
Non-Small Cell Lung Cancer
Enrollment
120 pts
Location
United States, Brazil, France
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada, Mexico
Sponsor
Canadian Cancer Trials Group
View Trial →
Page 5 of 8 — 195 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology